Literature DB >> 7789963

Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations.

H Ida1, K Iwasawa, H Kawame, O M Rennert, K Maekawa, Y Eto.   

Abstract

The prevalence of seven different mutations (84GG, IVS2 + 1, 754A, 1226G, 1342C, 1448C, and 1504T) was investigated in 32 unrelated Japanese Gaucher patients of which 20 were type I, 6 were type II, and 6 were type III). These mutations constitute 95% of the mutations observed in Jewish patients with Gaucher disease and 75% of the mutations in non-Jews (European). The most frequent mutation, 1448C (L444P), accounted for 26 alleles (40.6%); the second most prevalent mutation was 754A (F213I), accounting for 7 alleles (10.9%); 27 alleles (42.2%) were unidentified. To data, neither the 1226G (N370S) nor 84GG mutations have been identified in the Japanese population though these alleles account for approximately 70% and 10% of mutations in the Jewish population. These data suggest that mutant alleles identified from the Japanese population are distinct from those observed in Jewish and non-Jewish (European) patients with Gaucher disease.

Entities:  

Mesh:

Year:  1995        PMID: 7789963     DOI: 10.1007/bf00209497

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

Review 1.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

2.  Gaucher disease mutations in non-Jewish patients.

Authors:  E Beutler; T Gelbart
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

3.  Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

Authors:  D Glenn; T Gelbart; E Beutler
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

4.  Type 1 Gaucher disease: molecular, biochemical, and clinical characterization of patients from northern Portugal.

Authors:  O Amaral; L Lacerda; R Santos; R A Pinto; H Aerts; M C Sa Miranda
Journal:  Biochem Med Metab Biol       Date:  1993-02

5.  Gaucher disease: gene frequencies in the Ashkenazi Jewish population.

Authors:  E Beutler; N J Nguyen; M W Henneberger; J M Smolec; R A McPherson; C West; T Gelbart
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

Review 6.  Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.

Authors:  S Zevin; A Abrahamov; I Hadas-Halpern; R Kannai; E Levy-Lahad; M Horowitz; A Zimran
Journal:  Q J Med       Date:  1993-09

7.  Sequence of two alleles responsible for Gaucher disease.

Authors:  C M Hong; T Ohashi; X J Yu; S Weiler; J A Barranger
Journal:  DNA Cell Biol       Date:  1990-05       Impact factor: 3.311

8.  Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.

Authors:  G S He; G A Grabowski
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

9.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

10.  Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuronopathic form.

Authors:  M Masuno; S Tomatsu; K Sukegawa; T Orii
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

View more
  12 in total

1.  Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease.

Authors:  N Tayebi; S Cushner; E Sidransky
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

2.  Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations.

Authors:  H Ida; O M Rennert; H Kawame; K Maekawa; Y Eto
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

3.  D409H/D409H genotype in Gaucher-like disease.

Authors:  E Uyama; M Uchino; H Ida; Y Eto; M Owada
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

4.  Severe skeletal complications in Japanese patients with type 1 Gaucher disease.

Authors:  H Ida; O M Rennert; S Kato; T Ueda; K Oishi; K Maekawa; Y Eto
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

5.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

6.  Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.

Authors:  D P Germain; J P Puech; C Caillaud; A Kahn; L Poenaru
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.

Authors:  Sakura Hosoba; Katsuyuki Kito; Yukako Teramoto; Kaori Adachi; Ryota Nakanishi; Ai Asai; Masaki Iwasa; Rie Nishimura; Suzuko Moritani; Masahiro Kawahara; Hitoshi Minamiguchi; Eiji Nanba; Ryoji Kushima; Akira Andoh
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects.

Authors:  Yoo-Mi Kim; Jin-Ho Choi; Gu-Hwan Kim; Young Bae Sohn; Jung Min Ko; Beom Hee Lee; Chong Kun Cheon; Han Hyuk Lim; Sun-Hee Heo; Han-Wook Yoo
Journal:  Orphanet J Rare Dis       Date:  2020-11-11       Impact factor: 4.123

Review 9.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

10.  Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.

Authors:  Aya Narita; Kentarou Shirai; Shinji Itamura; Atsue Matsuda; Akiko Ishihara; Kumi Matsushita; Chisako Fukuda; Norika Kubota; Rumiko Takayama; Hideo Shigematsu; Anri Hayashi; Tomohiro Kumada; Kotaro Yuge; Yoriko Watanabe; Saori Kosugi; Hiroshi Nishida; Yukiko Kimura; Yusuke Endo; Katsumi Higaki; Eiji Nanba; Yoko Nishimura; Akiko Tamasaki; Masami Togawa; Yoshiaki Saito; Yoshihiro Maegaki; Kousaku Ohno; Yoshiyuki Suzuki
Journal:  Ann Clin Transl Neurol       Date:  2016-02-02       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.